Rapid Communication
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 21, 2007; 13(27): 3726-3729
Published online Jul 21, 2007. doi: 10.3748/wjg.v13.i27.3726
Figure 1
Figure 1 Strong immuno-reactivity of ezrin in grade II intestinal type gastric adenocar-cinoma cells (IHC, x 200).
Figure 2
Figure 2 Cytoplasmic immunpositivity of ezrin in poorly differentiated gastric adenocarcinoma (IHC, x 200).
Figure 3
Figure 3 Negative staining in atypical cells for ezrin in diffuse type gastric carcinoma. Positive staining in normal gastric glands (IHC, x 200).